Concepedia

Kyle Flannery

KF

Statistics

Publications

3

Citations

85

H-Index

3

Active since

2017

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Kyle Flannery is an author at The University of Texas MD Anderson Cancer Center specializing in urologic cancer epidemiology, outcomes research, and cancer research.

Top concepts

Publications per year

2017–2019

3

Publications

3

Outcomes In Patients With Metastatic Bladder Cancer In The Usa: A Retrospective Electronic Medical Record Study

Kyle Flannery, Marley Boyd, Jenny Black-Shinn et al. · Future Oncology · 2019 · 44 citations

, , +14

Survival Rates and Health Care Costs for Patients With Advanced Bladder Cancer Treated and Untreated With Chemotherapy

Kyle Flannery, Xiting Cao, Jinghua He et al. · Clinical Genitourinary Cancer · 2018 · 23 citations · Full text

Budgetary Impact of Cabazitaxel Use After Docetaxel Treatment for Metastatic Castration-Resistant Prostate Cancer

Kyle Flannery, Ed Drea, Louis Hudspeth et al. · Journal of Managed Care & Specialty Pharmacy · 2017 · 18 citations · Full text

1–3 of 3